BME
BlackRock Health Sciences Trust
43.10$
+1.2%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q4 24 | Q2 25 | Q4 25 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 35.7% | 85.8% | 328.6% | 39.2% | 458.0% | -9.6% | 436.7% | – | 2.6% | 128.7% | -41.5% | – | |
| -869.9% | 44.7% | 11.3% | – | – | – | – | – | – | – | – | – | |
| 3.2% | 23.9% | 51.7% | 13.3% | -75.4% | -16.2% | 28.8% | – | -1.8% | 27.9% | -1.6% | – | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | 0.0% | 0.0% | 0.0% | 0.0% | |
| – | – | – | 70.2% | – | 126.4% | – | – | 145.6% | 635.8% | 53.3% | – | |
| 419.4% | 3,088.0% | 401.8% | 103.0% | 457.1% | 98.4% | 435.2% | – | 49.8% | 512.7% | 89.3% | – | |
| -383.3% | -1,411.1% | -73.1% | -9.4% | – | – | – | – | -80.4% | -353.2% | – | – | |
| -0.1% | 8.7% | 2.2% | – | – | – | – | – | – | – | – | – | |
| -36.1% | -265.7% | -328.7% | -84.3% | -458.0% | -98.6% | -436.7% | – | -130.2% | -866.0% | -89.3% | – | |
| -0.3% | -2.5% | -0.1% | 0.0% | 0.0% | 0.0% | 0.0% | – | 0.0% | 0.8% | -0.2% | – | |
| 35.7% | 85.8% | 328.6% | 39.2% | 458.0% | -9.6% | 436.7% | – | 2.6% | 866.8% | -41.5% | – |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.